ACON BioMatrix Investors I, L.L.C. — Form D

ACON BioMatrix Investors I, L.L.C. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-01. The offering totals $57.5M, of which $57.5M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (9)

NameRoleLocation
Not Applicable R ACON EQUITY MANAGEMENT, L.L.C.Executive OfficerWASHINGTON, DC
BERNARD R ARONSONExecutive OfficerWASHINGTON, DC
TERESA R BERNSTEINExecutive OfficerWASHINGTON, DC
ANDRE R BHATIAExecutive OfficerWASHINGTON, DC
Kenneth R BrotmanExecutive OfficerWashington, DC
JONATHAN R GINNSExecutive OfficerWASHINGTON, DC
DANIEL R JINICHExecutive OfficerWASHINGTON, DC
BARRY R JOHNSONExecutive OfficerWASHINGTON, DC
Aron R SchwartzExecutive OfficerWashington, DC

More